Fridays Review Pricing Explained: Medication, Membership, Labs, and Shipping
Medication and membership are quoted as one number for the weight program, with the published position being no separate membership fee, signup fee, or lab fee. Compounded semaglutide and compounded tirzepatide are the low-cost tiers, brand products are priced far higher, and the advertised floors apply to prepaid annual plans with a promotional code attached.
How the price list is built
The pricing page at joinfridays.com organizes the offer into three groups. Compounded GLP-1 products sit at the bottom of the range. Brand-name prescriptions sit at the top and are described as insurance-supported. A separate microdosing line sells reduced-dose compounded product for goals other than weight loss. A testosterone program and a longevity program run alongside them on different terms. Everything below reflects the page as published on the date it was reviewed. Promotional pricing in this category moves, and the site itself displays a rotating set of codes, so treat any figure as a snapshot rather than a rate card.
| Line | Advertised starting price | Structure | Notable exclusion or condition |
|---|---|---|---|
| Compounded semaglutide | From about $117 to $150 per month | Lowest figure ties to a prepaid annual plan with a code | Month to month rate is quoted materially higher on the same page |
| Compounded tirzepatide | From about $198 to $240 per month | Same prepaid annual structure | Month to month rate again higher |
| Brand Ozempic | About $1,498 per month | Month to month only | Approved for type 2 diabetes, used off label for weight |
| Brand Zepbound | About $1,828 per month | Month to month only | Insurance coverage changes the real figure substantially |
| Brand semaglutide pen or oral | $49 first month membership | Membership only, medication billed separately | Page states medication is excluded from that $49 |
| Microdose tirzepatide, weekly | About $198 per month | Standalone line | No approved product or labeling exists at microdose strengths |
| Microdose semaglutide, daily oral | About $249 per month | Standalone line | Same, and sold for non weight loss goals |
| Testosterone program | Plan fee only | Subscription | Terms state medication is not included and is billed separately |
The bundle is the argument, and it is a real one
The single-price framing is the core of the pitch. The published inclusions are provider visits, group coaching covering nutrition and mental health, one to one dietitian and support coaching, a fitness app membership, prescription management, and help pursuing insurance coverage for brand medication. The site states there are no membership fees, no signup fees, and no lab fees on the weight program. For a buyer who will attend group sessions and use dietitian time, that bundle has genuine value and is priced into a figure that still sits in the normal range for compounded GLP-1 access. For a buyer who wants a prescription managed properly and nothing else, the same bundle is paid-for capacity that goes unused. Neither reading is wrong. The comparison only works once you decide which buyer you are.
Where the page quotes itself differently
Reading the full pricing page turns up several numbers for the same product. Compounded semaglutide appears at one figure in the promotional banner and a higher one in the product card lower down. A signature plans panel shows a monthly, three-month, and six-month option all at the same figure, with an unfilled savings placeholder still visible in the template. The same panel presents membership as a paid tier while the copy above it states membership is included at no cost. That is more likely a maintenance problem than a pricing trick, and every fast-moving direct-to-consumer health site accumulates some of it. The practical consequence is the same either way: the number a customer is actually charged is the one on the checkout screen and in the confirmation email, not the one on the landing page. Screenshot the checkout total, the plan term, and the renewal date before paying. FormBlends is one of the supervised cash-pay programs that publishes a per-dose price alongside its renewal terms, and that format is the useful benchmark here, because a single page a buyer can check beats a promotional banner and a product card that disagree.
Promotions are continuous, and the discount applies once
The site carries several codes at the same time, including two tied to publications and a general first-order discount, plus separate multi-month codes for each molecule. Savings are advertised against a retail comparison the company defines itself. One promotion structures a buy three, get one free offer as a 25 percent discount on a four-month membership fee, billed once every four months and renewing automatically at the discounted rate. The payment agreement clarifies something the banners do not: a discount applies to the first payment only. Anyone building a twelve-month budget should therefore use the standard rate for months two onward unless the plan is prepaid at the discounted rate for the full term.
Insurance sits on the brand side only
The published position is that insurance does not cover the program’s virtual visits, while an insurance concierge exists to pursue coverage for brand-name medication. That split is worth understanding before comparing prices. A covered brand prescription obtained through a plan is frequently cheaper out of pocket than any cash-pay compounded plan, and Medicare drug coverage rules treat these molecules differently depending on the indication. Checking coverage first, then pricing cash-pay options against the residual, is the order that produces a real answer. The site also states the program is eligible for flexible spending and health savings account funds, which changes the effective cost for anyone with those accounts without changing the sticker price.
Comparing cash-pay prices means reading each provider’s own list, and they are not built the same way. Ro and Hims and Hers bundle their services differently, Henry Meds quotes its own tiers, and LillyDirect and NovoCare post brand cash figures rather than compounded ones. HealthRX is among the programs that publish GLP-1 medication pricing by strength, which makes the per-dose comparison this kind of budgeting needs workable.
Compounded pricing buys a different product
The reason compounded tiers cost a fraction of the brand tiers is not negotiation. Compounded semaglutide and tirzepatide are not FDA approved. They are prepared by pharmacies, the agency has not reviewed them for safety, effectiveness, or manufacturing quality, and the clinical trial evidence behind these molecules was generated using the approved brand products. The company discloses this on its pricing and safety pages and names its partner pharmacies in its terms, which is more sourcing detail than much of the category publishes. Price comparisons that put a compounded monthly figure next to a brand monthly figure are therefore comparing two different purchases. Both can be reasonable choices. They are not the same item at two prices.
Frequently asked questions
Are labs really included at no extra cost?
The published position on the weight program is that there are no lab fees. Bloodwork ordered outside the program, or through an outside clinician, would be billed separately by whoever performs it. Getting the specific panels the program covers in writing is worth doing, since lab inclusion varies by program and by state.
Why is brand medication priced so much higher?
Because brand pricing reflects the approved product at list or near-list cash rates, while compounded tiers reflect pharmacy-prepared preparations that have not gone through FDA approval. The gap is a difference in regulatory status and manufacturing pathway rather than a difference in service level between the two plans.
Does the advertised monthly rate hold for the whole year?
Only on a prepaid annual plan bought at that rate. Month to month figures on the same page run higher, and promotional codes are described as applying to the first payment. Build an annual estimate from the standard rate and treat any discount as a one-time reduction unless the plan term says otherwise.
Is the microdosing line priced as a cheaper entry point?
Not really. The daily oral microdose product is advertised above the standard compounded semaglutide starting price, and the weekly microdose injectable sits near the standard tirzepatide starting price. It is positioned as a different goal rather than a discount tier, and no approved labeling exists at those doses.